90 related articles for article (PubMed ID: 12203790)
1. Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma.
Schulz WA; Elo JP; Florl AR; Pennanen S; Santourlidis S; Engers R; Buchardt M; Seifert HH; Visakorpi T
Genes Chromosomes Cancer; 2002 Sep; 35(1):58-65. PubMed ID: 12203790
[TBL] [Abstract][Full Text] [Related]
2. Factor interaction analysis for chromosome 8 and DNA methylation alterations highlights innate immune response suppression and cytoskeletal changes in prostate cancer.
Schulz WA; Alexa A; Jung V; Hader C; Hoffmann MJ; Yamanaka M; Fritzsche S; Wlazlinski A; Müller M; Lengauer T; Engers R; Florl AR; Wullich B; Rahnenführer J
Mol Cancer; 2007 Feb; 6():14. PubMed ID: 17280610
[TBL] [Abstract][Full Text] [Related]
3. Tissue-specific DNA methylation loss during ageing and carcinogenesis is linked to chromosome structure, replication timing and cell division rates.
Dmitrijeva M; Ossowski S; Serrano L; Schaefer MH
Nucleic Acids Res; 2018 Aug; 46(14):7022-7039. PubMed ID: 29893918
[TBL] [Abstract][Full Text] [Related]
4. Measuring cancer driving force of chromosomal aberrations through multi-layer Boolean implication networks.
Cosentini I; Condorelli DF; Locicero G; Ferro A; Pulvirenti A; Barresi V; Alaimo S
PLoS One; 2024; 19(4):e0301591. PubMed ID: 38593144
[TBL] [Abstract][Full Text] [Related]
5. DNA hypomethylation in the origin and pathogenesis of human diseases.
Pogribny IP; Beland FA
Cell Mol Life Sci; 2009 Jul; 66(14):2249-61. PubMed ID: 19326048
[TBL] [Abstract][Full Text] [Related]
6. Expression of Concern: Unique Association between Global DNA Hypomethylation and Chromosomal Alterations in Human Hepatocellular Carcinoma.
PLOS ONE Editors
PLoS One; 2023; 18(1):e0279150. PubMed ID: 36630348
[No Abstract] [Full Text] [Related]
7. Circulating Chromosome Conformation Signatures Significantly Enhance PSA Positive Predicting Value and Overall Accuracy for Prostate Cancer Detection.
Pchejetski D; Hunter E; Dezfouli M; Salter M; Powell R; Green J; Naithani T; Koutsothanasi C; Alshaker H; Jaipuria J; Connor MJ; Eldred-Evans D; Fiorentino F; Ahmed H; Akoulitchev A; Winkler M
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765779
[TBL] [Abstract][Full Text] [Related]
8. Monocytes acquire prostate cancer specific chromatin conformations upon indirect co-culture with prostate cancer cells.
Alshaker H; Hunter E; Salter M; Ramadass A; Westra W; Winkler M; Green J; Akoulitchev A; Pchejetski D
Front Oncol; 2022; 12():990842. PubMed ID: 36059613
[TBL] [Abstract][Full Text] [Related]
9. The Cellular and Molecular Immunotherapy in Prostate Cancer.
Mukherjee AG; Wanjari UR; Prabakaran DS; Ganesan R; Renu K; Dey A; Vellingiri B; Kandasamy S; Ramesh T; Gopalakrishnan AV
Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016257
[TBL] [Abstract][Full Text] [Related]
10. Race and prostate cancer: genomic landscape.
Arenas-Gallo C; Owiredu J; Weinstein I; Lewicki P; Basourakos SP; Vince R; Al Hussein Al Awamlh B; Schumacher FR; Spratt DE; Barbieri CE; Shoag JE
Nat Rev Urol; 2022 Sep; 19(9):547-561. PubMed ID: 35945369
[TBL] [Abstract][Full Text] [Related]
11. Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer.
Pardo JC; Ruiz de Porras V; Gil J; Font A; Puig-Domingo M; Jordà M
Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215499
[TBL] [Abstract][Full Text] [Related]
12. Misregulation of the expression and activity of DNA methyltransferases in cancer.
Mensah IK; Norvil AB; AlAbdi L; McGovern S; Petell CJ; He M; Gowher H
NAR Cancer; 2021 Dec; 3(4):zcab045. PubMed ID: 34870206
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic Editing in Prostate Cancer: Challenges and Opportunities.
Pacheco MB; Camilo V; Henrique R; Jerónimo C
Epigenetics; 2022 May; 17(5):564-588. PubMed ID: 34130596
[TBL] [Abstract][Full Text] [Related]
14. Dietary Methionine Deficiency Enhances Genetic Instability in Murine Immune Cells.
Binz RL; Sadhukhan R; Miousse IR; Garg S; Koturbash I; Zhou D; Hauer-Jensen M; Pathak R
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673497
[TBL] [Abstract][Full Text] [Related]
15. Chromatin conformation changes in peripheral blood can detect prostate cancer and stratify disease risk groups.
Alshaker H; Mills R; Hunter E; Salter M; Ramadass A; Skinner BM; Westra W; Green J; Akoulitchev A; Winkler M; Pchejetski D
J Transl Med; 2021 Jan; 19(1):46. PubMed ID: 33509203
[TBL] [Abstract][Full Text] [Related]
16. Aberrant Methylation of LINE-1 Transposable Elements: A Search for Cancer Biomarkers.
Ponomaryova AA; Rykova EY; Gervas PA; Cherdyntseva NV; Mamedov IZ; Azhikina TL
Cells; 2020 Sep; 9(9):. PubMed ID: 32887319
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of prostate cancer: the theories and the clinical implications.
Liao Y; Xu K
Asian J Androl; 2019; 21(3):279-290. PubMed ID: 30084432
[TBL] [Abstract][Full Text] [Related]
18. A novel long non-coding RNA from NBL2 pericentromeric macrosatellite forms a perinucleolar aggregate structure in colon cancer.
Dumbovic G; Biayna J; Banús J; Samuelsson J; Roth A; Diederichs S; Alonso S; Buschbeck M; Perucho M; Forcales SV
Nucleic Acids Res; 2018 Jun; 46(11):5504-5524. PubMed ID: 29912433
[TBL] [Abstract][Full Text] [Related]
19. Prostate Cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities.
Tan SH; Petrovics G; Srivastava S
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29690565
[TBL] [Abstract][Full Text] [Related]
20. Aberrant methylated key genes of methyl group metabolism within the molecular etiology of urothelial carcinogenesis.
Erichsen L; Ghanjati F; Beermann A; Poyet C; Hermanns T; Schulz WA; Seifert HH; Wild PJ; Buser L; Kröning A; Braunstein S; Anlauf M; Jankowiak S; Hassan M; Bendhack ML; Araúzo-Bravo MJ; Santourlidis S
Sci Rep; 2018 Feb; 8(1):3477. PubMed ID: 29472622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
